Sustained adherence to ESC guideline-recommended medications is associated with lower long-term mortality in heart failure and reduced ejection fraction: Insights from the EPICAL2 cohort.
Fiche publication
Date publication
mai 2020
Journal
Journal of clinical pharmacy and therapeutics
Auteurs
Membres identifiés du Cancéropôle Est :
Pr THILLY Nathalie
Tous les auteurs :
Bitar S, Thilly N, Agrinier N
Lien Pubmed
Résumé
The real-life prognostic impact on long-term survival of continuous or discontinuous adherence to ESC guideline-recommended drugs in heart failure with reduced ejection fraction (HFrEF) patients has rarely been investigated. Here, we present the long-term association of longitudinal prescription of guideline-recommended drugs with 3-year all-cause and cardiovascular (CV) mortality in HFrEF patients.
Mots clés
guidelines, heart failure, long-term outcomes, medication, reduced ejection fraction
Référence
J Clin Pharm Ther. 2020 May 27;: